By Brian French | BusinessNewsFlorida.com | September 9, 2026

Quick Answer

Florida’s drug testing market is dominated by two national laboratories (Quest Diagnostics and Labcorp), one occupational-health clinic chain (Concentra), one private-equity-backed program administrator (DISA Global Solutions), and one homegrown administrator on the Space Coast (National Drug Screening). Between them they handle the bulk of the state’s employment, DOT, and court-related screening. The state’s 1990 drug-free workplace statute, which rewards compliant employers with a workers’ compensation discount, keeps demand steady regardless of the economic cycle.

The Business Behind the Cup

Most Florida executives think of a drug test as a $40 line item on an onboarding checklist. In reality it sits at the end of a supply chain with four distinct layers, and the money flows differently at each one.

At the bottom is the collection site: a clinic, a patient service center, or a mobile collector who watches the paperwork and seals the specimen. Above that is the laboratory, where the specimen is screened, confirmed, and reported under federal certification. Above the lab is the Medical Review Officer, a licensed physician who verifies any non-negative result and speaks with the donor about prescriptions. At the top is the third-party administrator, or TPA, which the employer actually hires to run the whole program, manage random pools, and keep the audit file clean.

Almost no company owns all four layers. The five firms profiled here each dominate one or two, and understanding which layer a provider occupies is the single most useful thing a Florida buyer can know before signing a contract.

What Makes Florida Different

Florida’s incentive structure is the reason its testing volume punches above the state’s share of the national workforce. The state’s drug-free workplace program dates to 1990 legislation, and employers who maintain a qualifying program earn a 5% reduction on workers’ compensation premiums. In an economy heavy with construction, warehousing, hospitality, and healthcare, that discount adds up to real money for large payrolls, and it comes with procedural protections when a worker is injured while impaired.

The second Florida variable is cannabis policy. The state has close to a million qualified medical marijuana patients, while recreational use is still prohibited after voters declined to pass the 2024 legalization amendment. Employers therefore face rising positivity without the legal ambiguity found in fully legalized states.

National numbers show where that pressure is heading. Quest’s newest analysis found that hair-specimen positivity among general-workforce employees hit 19.1% in 2025, up roughly 46% from 2021, with cannabis the main driver. The urine-based picture is calmer: overall positivity edged down to 4.4% from 4.6%, and marijuana held at 4.5% in the general workforce. One encouraging signal for safety-sensitive employers is that fentanyl positivity in the general workforce fell by nearly half, from 0.55% in 2024 to 0.28% in 2025.

Ranking Methodology

We assessed each firm on where it sits in the value chain, how much of Florida it physically covers, and how much annual testing activity it disclosed. No provider publishes Florida-only volumes, so the order below is an analyst’s composite of public filings, company statements, and industry reporting rather than an official league table.

Snapshot: The Big Five in Florida

#ProviderLayerBaseFlorida Signal
1Quest DiagnosticsLab + collectionNew JerseyTampa lab; statewide service centers
2LabcorpLab + collectionNorth CarolinaLocations in 60+ FL cities
3ConcentraClinic collectionTexasCenters from Ocala to Florida City
4DISA Global SolutionsTPATexasFIU among institutional clients
5National Drug ScreeningTPA + MROMelbourne, FLOnly FL-headquartered firm on list

1. Quest Diagnostics: The Volume Leader

Quest is the largest clinical laboratory company in the country, and workforce drug screening is one of its longest-running product lines. The company was founded in 1967 in New York City, is headquartered in Secaucus, New Jersey, trades on the NYSE as DGX, reported $11.0 billion in 2025 revenue, and employs about 65,000 people.

Where it operates in Florida

Quest lists a Tampa Laboratory Facility on East Fowler Avenue, and its patient service centers across the state serve as employer collection points. The company describes its retail footprint as one of 2,000+ locations where you can complete sample collection for both doctor-ordered and self-purchased lab work.

What sets it apart

Quest’s dominance is reinforced by information. Its Drug Testing Index has tracked workplace positivity rates for the company’s employer clients since 1988, and the company publishes the results publicly for policymakers and employers. The 2025 edition drew on more than 8 million tests.

The most consequential finding for Florida safety managers came from random testing. In 2024, fentanyl positivity in random tests among the general workforce (1.13%) ran 707% higher than in pre-employment screens (0.14%). Workers were clearing their hiring test and using afterward. Quest also reported that among federally mandated, safety-sensitive workers, for-cause positivity was 12.6% compared to 14.5% in 2023, evidence that structured programs suppress positivity.

For the Florida buyer, the practical point is that Quest is frequently the lab behind the TPA you hire, whether or not you ever deal with Quest directly.

2. Labcorp: The Statewide Alternative

Labcorp is the other half of the American reference-lab duopoly, and its Florida coverage rivals Quest’s. A scan of its own directory shows patient service centers in communities from Pensacola and Panama City in the Panhandle through Tallahassee, The Villages, Tampa, Sarasota, Vero Beach, West Palm Beach, Weston, and dozens more.

How Florida employers use it

Labcorp markets its Florida centers for laboratory testing, drug testing, and routine labwork, with online ordering or walk-in options. That walk-in path is what makes Labcorp a go-to for individuals who need a personal, probation, or court-ordered test without an employer account.

Competitive position

Labcorp and Quest are functionally interchangeable for most Florida employers; the deciding factor is usually which lab a TPA’s software is wired to. As one Florida TPA notes, its scheduling platform handles paperless e-chain tests for LabCorp, Quest, and FormFox enabled collection sites. That interoperability is why the two labs, rather than any regional player, form the infrastructure layer of the state’s market.

3. Concentra: The Clinic Network

Concentra occupies the collection layer at a scale no independent site can approach. It is an occupational medicine company first, and drug screening rides alongside pre-employment physicals, injury treatment, and physical therapy.

National scale

The company was founded in 1979, employs more than 12,000, treats an average of over 50,000 patients per day, and operates 625+ occupational health centers plus 410+ onsite employer clinics. Its substance abuse management program reaches further, with more than 3,000 drug testing locations in network.

Florida footprint

Concentra’s Florida centers stretch from Ocala through Orlando to Florida City at the southern edge of Miami-Dade. Its Orlando North center, for instance, offers drug screening, physicals, other pre-employment services, urgent care, and immunizations under one roof, and lists access to Concentra Advanced Specialists in hand surgery, orthopedics, and physiatry.

Why employers choose it

Speed. Concentra states that urine and recent-use oral fluid screens are available at all of its centers for non-regulated testing, with rapid technology identifying a negative test within minutes. Regulated and non-negative specimens go to a federally certified SAMHSA laboratory, and MRO follow-up and confirmation typically finish within three to five business days. The company can also act purely as a collection point for a client’s chosen lab or TPA, in which case results flow through that third party.

For a Florida staffing agency or general contractor filling a crew on short notice, a negative-in-minutes clinic is the difference between a worker starting today and starting Thursday.

4. DISA Global Solutions: The Compliance Engine

DISA is the largest pure administrator in the country and the firm most likely to be running the drug and alcohol program at a Florida trucking company, refinery, or port operator.

Scale and ownership

DISA describes itself as the industry’s largest drug testing provider in 2026, administering 3 million drug tests annually. The company has offered employee screening since 1987, spanning drug and alcohol testing, background screening, occupational medicine and testing, safety training, and transportation compliance. It is a portfolio company of The Riverside Company, which characterizes it as a leading provider of safety services and international employee screening services.

Florida relationships

DISA has no Florida laboratory; it manages programs through a national collection network. Its client roster in the state includes higher education. Florida International University is quoted on DISA’s site praising the platform for streamlined student screening and compliance management.

Value proposition

DISA sells regulatory vigilance more than the test itself. Its 2026 guidance to transportation clients addresses the FMCSA Final Rule that tightened non-domiciled CDL eligibility with stricter visa requirements, updated verification standards, and tighter expiration rules. It packages flexible programs covering pre-employment, random, post-accident, and return-to-duty testing, and pitches integration with ATS/HRIS systems, consolidated reporting, and analytics.

5. National Drug Screening: Florida’s Own

National Drug Screening is the Florida-headquartered entry on this list and a case study in how a regional administrator competes with national capital.

Company profile

NDS is privately held, founded in 1993, and headquartered on West Hibiscus Boulevard in Melbourne, with stated specialties in drug testing, drug training, MRO software, and drug screening. The company outgrew its prior Waverly Place office and moved into a larger facility in late 2022.

Business model

NDS combines a technology platform with Medical Review Officer services, testing, training, and consultation, offered to small and medium-size TPA operations as well as directly to employers. Its stated service list includes scheduling at collection sites nationwide, automated results reporting, online random program management, electronic data management, drug-free workplace policy development, and employer and collector training programs.

Leadership credibility

President Joe Reilly served nine years on the board of the Drug & Alcohol Testing Industry Association beginning in 2001 and chaired the DATIA board from 2004 to 2008. His résumé includes specimen collection contract work for Major League Baseball and Minor League Baseball in 2003 and 2004, and consulting for the Florida Office of Drug Control and the Florida Department of Corrections. The firm also runs training for entrepreneurs entering the drug testing business, effectively seeding its own future competitors and customers.

Other Florida Players Worth Knowing

  • Coastal Drug Testing positions itself as the state’s top provider with testing locations in Cape Canaveral, Miami, Orlando/Winter Park, Tampa and Jacksonville and affiliates elsewhere in Florida.
  • Drug Testing Services of Florida operates from Daytona Beach and describes itself as a full-service drug, alcohol, nicotine, and DNA screening company.
  • US Drug Test Centers claims to be one of the largest nationwide providers of drug and alcohol testing, offering access to thousands of collection sites, with a cloud portal for Florida employers.
  • Franchise brands including ARCpoint Labs and Any Lab Test Now fill the retail, walk-in gap in most Florida metros.

Brian’s Take

When I was managing money, the first question on any company was: what part of the chain captures the margin, and can anyone else get there? Apply that here and the picture is clear.

The laboratories are the toll road. Federal certification, chain-of-custody systems, and Quest’s 38-year dataset are effectively unreplicable, which is why every other firm on this list ultimately routes through Quest or Labcorp. Labcorp and Quest will not lose share to a Florida upstart in my lifetime.

The clinic layer is a real estate and throughput game. Concentra wins because its centers are already where the workers are and because a physical, a titer, and a drug screen can happen in one visit. The threat to Concentra is not another clinic chain; it is oral fluid and mobile collection moving the specimen to the jobsite.

The administrator layer is where Florida companies can still build value. DISA’s scale is formidable, but National Drug Screening proves that a focused TPA with strong MRO services, decent software, and an owner who literally chaired the industry association can carve out durable share from Melbourne. Every regulatory change, whether fentanyl on federal panels, the FMCSA CDL rule, or Florida’s slow-motion cannabis debate, adds complexity that employers will pay someone to absorb.

My forecast: consolidation continues at the top, oral fluid testing erodes clinic traffic at the margin over the next three years, and Florida employers in non-safety roles begin narrowing marijuana testing while safety-sensitive industries hold the line. The providers that help clients write defensible, job-specific policies will take share from those selling commodity screens.

Frequently Asked Questions

Are any of Florida’s largest drug testing companies actually based in Florida?

Only National Drug Screening, in Melbourne. Quest, Labcorp, Concentra, and DISA are headquartered out of state but maintain extensive Florida operations.

Is a drug-free workplace program mandatory in Florida?

No. It is voluntary for private employers, but Florida Statute 440.102 grants a 5% workers’ compensation premium discount to employers whose program meets the statutory requirements. DOT-regulated positions are governed separately by federal rules.

Which type of provider should a small Florida business hire?

A TPA. Firms like National Drug Screening or DISA handle scheduling, random selection, MRO review, and recordkeeping, and they route specimens to Quest or Labcorp. Buying lab services directly rarely makes sense for a small payroll.

Can a Florida employer refuse to hire someone with a medical marijuana card who tests positive?

Generally yes. Florida law does not compel private employers to accommodate medical marijuana use, and employers may enforce drug-free workplace policies. Policy language should be reviewed by counsel, especially for non-safety-sensitive roles.

How fast are results?

Rapid point-of-care screens can flag a negative within minutes. Lab-confirmed negatives usually return in 24 to 48 hours. Non-negatives that need MRO review generally take three to five business days.

What is the difference between a lab and a TPA?

A laboratory analyzes the specimen under federal certification. A TPA administers the employer’s program and coordinates the lab, the collection site, and the MRO. Quest and Labcorp are labs; DISA and NDS are TPAs; Concentra is primarily a collection and occupational-health provider.

Sources and Further Reading

  1. Quest Diagnostics, 2025 Drug Testing Index press release (Sept. 2, 2025): https://newsroom.questdiagnostics.com/2025-09-02-Fentanyl-Positivity-Is-More-Than-Seven-Times-Higher-in-Random-Tests-vs-Pre-Employment-Drug-Screening,-Finds-2025-Quest-Diagnostics-Drug-Testing-Index
  2. Quest Diagnostics, 2026 hair-testing findings (July 10, 2026): https://www.prnewswire.com/news-releases/one-in-five-american-workers-tested-had-a-positive-hair-drug-test-in-2025-signaling-persistent-long-term-substance-use-patterns-302822819.html
  3. Quest Diagnostics, Drug Testing Index overview: https://www.questdiagnostics.com/business-solutions/employers/drug-screening/knowledge-center/drug-testing-index
  4. Quest Diagnostics, Tampa laboratory facility: https://www.questdiagnostics.com/locations/detail.html/laboratory-facilities–tampa
  5. Quest Diagnostics corporate profile (Wikipedia): https://en.wikipedia.org/wiki/Quest_Diagnostics
  6. Labcorp, Florida location directory: https://locations.labcorp.com/fl/
  7. Concentra, company overview: https://www.concentra.com/
  8. Concentra, employment drug testing: https://www.concentra.com/tests-and-screenings/drug-testing/
  9. Concentra, Orlando North center: https://www.concentra.com/urgent-care-centers/florida/miami/orlando-north-urgent-care/
  10. DISA Global Solutions, top drug testing companies 2026: https://disa.com/news/top-drug-testing-companies/
  11. DISA Global Solutions, company site and client testimonials: https://disa.com/
  12. The Riverside Company, DISA portfolio page: https://www.riversidecompany.com/investment-portfolio/disa-global-solutions
  13. National Drug Screening, LinkedIn profile: https://www.linkedin.com/company/national-drug-screening-inc-
  14. National Drug Screening, facility expansion announcement: https://www.nationaldrugscreening.com/blogs/national-drug-screening-expands-operations-with-move-to-larger-facility/
  15. National Drug Screening, Florida testing page: https://www.nationaldrugscreening.com/states/florida/
  16. NDASA member listing, National Drug Screening: https://ndasa.com/members/national-drug-screening-inc/
  17. Joe Reilly and Associates, biography: https://www.joereilly.com/about-joe-reilly/
  18. Coastal Drug Testing Florida: https://coastaldrugtestingflorida.com/
  19. US Drug Test Centers, Florida: https://www.usdrugtestcenters.com/drug-test-location/florida
  20. Florida Statutes §440.102: http://www.leg.state.fl.us/statutes/

About Brian French

This article combines human insight with tech-intelligent curation under our published Curation Protocols.Led by a commitment to tech-intelligent curation, Brian French tracks and analyzes Business News in Florida that defines Florida's economy. Brian brings an extensive financial background to his analysis, having graduated from the University of South Florida in Finance and serving as a Vice President and Portfolio Manager for Merrill Lynch Private Investors (a division of MLIM) and the Trust Department in St. Petersburg, FL, as well as a Vice President and Trust Investment Officer for SunTrust Bank in Sarasota, FL. His writing blends macroeconomic trends, capital markets analysis, corporate strategy, and modern digital insights for a sophisticated look at Florida's business news and economy.